Computational Aspects of Drug Design

Harshita Mahajan

BS-MS Third Year, Biological Sciences

What is drug discovery?

We can say that Drug Discovery is a process in which researchers design or discover novel chemical compounds that can act like drugs. Nowadays, scientists use various computational methods for drug discovery. By using these methods, we have reduced both time and cost involved in drug discovery work. This is because Computer-Aided Drug Design (CADD) methods drastically reduce the total number of compounds to be screened against the disease. The use of CADD methods is also labour efficient. Synthesis and biases are always laborious and the chance of getting false positives is always present after spending lots of physical and mental labour in finding a suitable drug.

In CADD, we mainly do structure-based drug design. This is aided by many software and programs specifically developed for drug design.

We start our journey by going to a protein data bank to choose our protein of interest. Protein Data Bank is a repository of crystal core structures that are experimentally solved by NMR spectroscopy or X-ray crystallography. There are different types of computational methods that we can use for the prediction of the structure of the target protein. Some of them are homology modelling, threading and ab initio modelling.

After finalising our protein we need to find the binding site so that the ligand of interest can go and bind to it. The dynamic nature of biomolecules sometimes makes it insufficient to use a single static structure to predict proper binding sites. What molecular dynamics does is, it generates multiple confirmed confirmations of our target protein that will be used for identification of the binding site. We will be looking at this in more detail in the upcoming portions of the article. Next prerequisite will be to have a mathematical description that we use to model and predict how atoms or molecules interact with each other at the atomic and molecular level.

Different Representations of the SARS-CoV super complex of non-structural proteins: the hexadecamer. These are what PDB files look like!

PDB ID : 2AHM

Another method used in CADD is Molecular docking. In general, docking is a procedure that predicts how two molecules interact, in our case the two molecules which are: target protein and the ligand. So molecular docking is a computational approach that predicts the favourable conformation of the ligand and its interactions in the binding site of the target protein. Some of the free sites available to the public are 1-Click Docking and AADS (developed by IIT Delhi).

Let us discuss how molecular docking can be used in drug discovery. The most important information we get from molecular docking is the configuration of the ligand molecule in the binding site of the target protein. There are different algorithms that we can use for generating conformations for our ligand molecule. From this, we can get the binding partners involved in both ligand molecules and the binding site amino acids. This information can be further exploited in the lead optimization procedures.

A drug molecule (Remdesivir) bound to its target protein and substrates

PDB ID : 7BV2

In the receptor-based pharmacophore model, by using a computer-aided drug design approach we attempt to identify all the chemical features that are present in the binding site of the target protein and use this information to screen its chemical database.

Molecular dynamics is a computational method that uses Newton's equations of motions to study movements of molecules. To quote from Springer’s “Molecular dynamics (MD) is a computational tool to simulate the motions of a molecular system. The method requires an interaction potential from which interatomic forces can be calculated and equations of motion that govern the dynamics of the system. Originally developed to study properties of the liquid state, MD simulations are nowadays routinely applied to macromolecular systems of biological and pharmaceutical interest.”

All these methodologies used have made drug designing a rapidly changing industry. We can see this from the fact that the vaccine for smallpox came nearly after 400-500 years of smallpox discovery whereas we can make vaccines for newer viruses within 2-3 years. For example, the recent COVID-19 pandemic forced researchers over the world to find a vaccine and Russia has actually found one which is now in the trial phase.

We are living in times where anything is possible or conceivable. Today we have reduced the time for drug production through CADD. Just imagine if after some years we are able to design drugs within days or hours by using CADD?

Fascinating, isn't it?